Trials / Completed
CompletedNCT01941563
A Study of SI-6603 in Patients With Lumbar Disc Herniation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 385 (actual)
- Sponsor
- Seikagaku Corporation · Industry
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of SI-6603 (condoliase) in patients with lumbar disc herniation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Condoliase | 1.25U, intradiscal injection, one time |
| DRUG | placebo |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2015-11-01
- Completion
- 2017-08-01
- First posted
- 2013-09-13
- Last updated
- 2023-03-23
Locations
32 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01941563. Inclusion in this directory is not an endorsement.